BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/13/2015 10:06:00 AM | Browse: 757 | Download: 903
Publication Name World Journal of Hepatology
Manuscript ID 13610
Country/Territory China
2014-08-28 08:17
Peer-Review Started
2014-08-29 08:24
To Make the First Decision
2014-10-14 18:09
Return for Revision
2014-10-20 17:40
2014-11-10 14:26
Second Decision
2015-01-29 09:18
Accepted by Journal Editor-in-Chief
2015-01-29 16:42
Accepted by Company Editor-in-Chief
2015-02-09 10:40
Articles in Press
2015-02-09 10:40
Publication Fee Transferred
Edit the Manuscript by Language Editor
2015-02-11 23:42
Typeset the Manuscript
2015-04-21 13:58
Publish the Manuscript Online
2015-05-13 10:06
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Review
Article Title Immunotherapy for hepatocellular carcinoma: From basic research to clinical use
Manuscript Source Invited Manuscript
All Author List Yu-Peng Hong, Zi-Duo Li, Pankaj Prasoon and Qi Zhang
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 81401954
Corresponding Author Qi Zhang, MD, Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou 310009, Zhejiang Province, China. zhangqi86@gmail.com
Key Words Interferon; Chemokine; Tumor vaccine; Adoptive immunotherapy; Chimeric antigen receptor; Checkpoint blockade
Core Tip This paper supplies a comprehensive review of immunotherapy for hepatocellular carcinoma from basic experiments to clinical trials. The development of interferon, chemokines, tumor vaccines, adoptive immunotherapy, including natural killer, natural killer T and T cells armed with chimeric antigen receptor, as well as regulatory T cell is summarized.
Publish Date 2015-05-13 10:06
Citation Hong YP, Li ZD, Prasoon P, Zhang Q. Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. World J Hepatol 2015; 7(7): 980-992
URL http://www.wjgnet.com/1948-5182/full/v7/i7/980.htm
DOI http://dx.doi.org/10.4254/wjh.v7.i7.980
Full Article (PDF) WJH-7-980.pdf
Full Article (Word) WJH-7-980.doc
Manuscript File 13610-Review.docx
Answering Reviewers 13610-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form 13610-Conflict-of-interest statement.pdf
Copyright License Agreement 13610-Copyright assignment.pdf
Peer-review Report 13610-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 13610-Journal Editor-in-Chief's Review Report.pdf
Scientific Misconduct Check 13610-Scientific misconduct check.pdf
Scientific Editor Work List 13610-Scientific editor work list.pdf